1. | jsarky4 | |
2. | chiling9259 | |
3. | fillyphan83 | |
4. | bobheany | |
5. | almasikhan |
1. | jsarky4 | |
2. | chiling9259 | |
3. | fillyphan83 | |
4. | bobheany | |
5. | almasikhan |
1. | fillyphan83 01/25/2018 H.C. Wainwright & Co. reiterates Buy rating, $8 PT |
2. | bobheany 01/29/2018 Goldman Sachs initiates as a neutral, $5.20PT |
3. | almasikhan 05/29/2018 T2 Biosystems Receives FDA Clearance to Market T2Bacteria Panel for Detection of Sepsis-Causing Pathogens |
4. | jsarky4 06/13/2018 Late-Breaking Data and Clinician Reviews on Now FDA-cleared T2Bacteria Panel Underscore Sepsis Prevention Opportunities at ASM Microbe 2018 |
5. | chiling9259 03/28/2018 Multiple New Studies Demonstrate T2 Biosystems' Diagnostics Improve Detection of Sepsis Causing Pathogens Over Blood Culture-based Diagnostics |
6. | jsarky4 01/05/2018 T2 Biosystems Announces Preliminary Fourth Quarter 2017 Financial Results and Provides Update on T2Bacteria Panel |